ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281617; 2) Community: the network communities that were significantly associated with the response to NSC 281617; 3) Molecule: the relationships between components within communities and NSC 281617; 4) MDR: the compounds that were significantly associated with the NSC 281617.

NSC Compound Enrichment Correlation
NSC 113951 6-Bromotoyocamycin 0.0414190425892865 0.12133971
NSC 116878 Cardiac glycoside 0.0414190425892865 0.36868
NSC 123978 Sarveroside 0.0414190425892865 0.48955969
NSC 154318 Methanesulfon-m-anisidide, 4'-[(3-chloro-5-methoxy-9-acridinyl)amino]-, monomethanesulfonate 0.0414190425892865 0.59437707
NSC 294814 3-Azabicyclo[3.2.2]nonane-3-carbothioic acid, [1-(2-pyridinyl)ethylidene]hydrazide 0.0414190425892865 -0.09421316
NSC 316158 Null 0.0414190425892865 0.14795045
NSC 363812 Tetraplatin 0.0414190425892865 0.2520809
NSC 625500 Null 0.0414190425892865 0.064904929
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.0414190425892865 0.30627064
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0414190425892865 0.097952342
Total:50  Current:35    [First] [Prev] [Next] [Last]